Baiyang Liu

机构：Shenzhen Technology University, Rice University · ORCID：0000-0002-8672-5146

发表论文 32 篇 · 总被引 3673 次 · h-index 12

代表论文

• The role of m6A modification in the biological functions and diseases (2021 · Signal Transduction and Targeted Therapy · 被引 2422)
• PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation (2020 · Theranostics · 被引 80)
• Hypoxia and cancer related pathology (2020 · Cancer Letters · 被引 67)
• miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer (2021 · Signal Transduction and Targeted Therapy · 被引 30)
• Research progress of gold, silver, and copper nanoclusters in bacterial infection diagnosis and treatment (2025 · Chemical Engineering Journal · 被引 13)
• Clinical research on Tai Chi: a review of health benefits (2024 · Acupuncture and Herbal Medicine · 被引 11)